Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus. November 18: Citizen Tribune November 18: Fox5 Vegas November 18: USA Life Sciences Database… Read More
In the transition from fetal to neonatal life, the kidneys undergo delicate and intricate changes in functionality as they assume the primary responsibility for keeping the blood clean and chemically balanced. Understanding these complex physiological changes is critical, as stressors before, during, and after delivery put newborns at risk of kidney injury and maladaptation. The… Read More
Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville and director of the Amyloidosis and Cancer Theranostics, has been awarded a two-year grant totaling $385,000 from the National Institute on Aging, part of the National Institutes of Health to study new treatments for systemic amyloidosis. Also:… Read More
Salvatore Mancarella, PhD, associate professor in the Department of Physiology in the College of Medicine at the University of Tennessee Health Science Center, was recently awarded $1.52 million from the National Institutes of Health (NIH) to support his investigations into the molecular-level causes of cardiac muscle deterioration. Also: BioEngineer
Siamak Yousefi, PhD, an assistant professor in the Department of Ophthalmology and the Department of Genetics, Genomics, and Informatics at the University of Tennessee Health Science Center, has received two grants worth more than $600,000 combined to further develop artificial intelligence (AI) to help diagnose and monitor glaucoma. Also: BioEngineer
Liza Makowski, PhD, a professor in the Department of Medicine-Hematology-Oncology at the University of Tennessee Health Science Center, and Joseph F. Pierre, PhD, an assistant professor in the Department of Pediatrics-Obesity at UTHSC, have received $2.1 million from the National Cancer Institute for a five-year study to examine how the microbiome impacts the immune system… Read More
Despite a plethora of treatment options, the burdens of cardiovascular and kidney disease still pose significant challenges to public health and the economy. Efforts to reduce cardiovascular and kidney disease include scientific investigations into the mechanisms that underlie alterations in the function of blood vessels. These efforts include the research done in the laboratory of… Read More
Ansley Grimes Stanfill, PhD, RN, associate dean of Research for the UTHSC College of Nursing, has been selected for the American Academy of Nursing’s 2020 Class of Fellows. Dr. Stanfill is also an alumna of UTHSC, earning her PhD in Nursing Science at the university in 2014. Also: BioEngineer
